Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies.

Antiviral therapy - 1 Jan 2014

Labarga Pablo, Fernández-Montero Jose V, López Mariola, Barreiro Pablo, de Mendoza Carmen, Sierra-Enguita Rocío, Treviño Ana, Soriano Vincent

Abstract excerpt

BACKGROUND: Because of their high cost, the use of direct-acting antivirals (DAAs) is being restricted by many governments to chronic HCV-infected individuals with advanced liver fibrosis. However, response rates are lower and toxicities more frequent in this subset of patients. METHODS: All HIV-HCV-coinfected patients followed for at least 3 years at one reference clinic were identified. Liver fibrosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Coinfection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Elasticity Imaging Techniques

Share to Hepacivirus

Share to Hepatitis C

Share to Liver Cirrhosis

Share to Severity of Illness Index

Share to Viral Load

Source

Identifiers

PMID: 24964405
DOI: 10.3851/IMP2816

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies.PMID 24964405Read ↗

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.Semantic proximity Read ↗

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.Semantic proximity Read ↗

HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.Semantic proximity Read ↗

Clinical features and therapeutic response in patients with HIV and acute HCV coinfection: a cohort studySemantic proximity Read ↗

Efficacy of Elbasvir/Grazoprevir in Early Chronic G1/G4 Hepatitis C infection in HIV/HCV co-infected patients with mild fibrosis.Semantic proximity Read ↗

Liver fibrosis progression in HIV/hepatitis C virus coinfected patients with normal aminotransferases levels.Semantic proximity Read ↗

Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia.Semantic proximity Read ↗

Evaluation of the therapeutic response of hepatitis C in coinfected patients (HIV/HCV): a study of cases from a hospital for chronic liver diseases in the Eastern Brazilian Amazon.Semantic proximity Read ↗

A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.Semantic proximity Read ↗

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.Semantic proximity Read ↗

Sustained virologic response and changes in liver fibrosis parameters following 12-wk administration of generic sofosbuvir and daclatasvir in HIV/HCV-coinfected patients with HCV genotype 4 infection.Semantic proximity Read ↗

Prediction of hepatic fibrosis in patients coinfected with HIV and hepatitis C virus based on genetic markers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.